Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Neuro-Oncology|August 23, 2018
UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenograftsEvan F Garner, Laura L Stafman, Adele P Williams, et al.
Translational Oncology|July 31, 2019
UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line XenograftsAdele P Williams, Evan F Garner, Laura L Stafman, et al.
Translational Oncology|April 22, 2021
Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like TumorColin H Quinn, Andee M Beierle, Adele P Williams, et al.
Translational Oncology|July 3, 2024
Preclinical evidence for employing MEK inhibition in NRAS mutated pediatric gastroenteropancreatic neuroendocrine-like tumorsColin H Quinn, Andee M Beierle, Adele P Williams, et al.
Cancers|April 23, 2022
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for NeuroblastomaLaura V Bownes, Raoud Marayati, Colin H Quinn, et al.
Cancers|February 15, 2022
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic VirotherapyColin H Quinn, Andee M Beierle, Sara Claire Hutchins, et al.
International Journal of Bioprinting|June 16, 2023
Using 3D-bioprinted models to study pediatric neural crest-derived tumorsColin H Quinn, Andee M Beierle, Janet R Julson, et al.
AIDS (London, England)|April 12, 2024
Plasma galectin-9 relates to cognitive performance and inflammation among adolescents with vertically acquired HIVPreeti Moar, Kyaw Linn, Thomas A Premeaux, et al.
Pageof 9